Biotechnology Bulletin ›› 2017, Vol. 33 ›› Issue (1): 135-140.doi: 10.13560/j.cnki.biotech.bull.1985.2017.01.015

• Orignal Article • Previous Articles     Next Articles

Biosynthesis of 3,4-dihydroxymandelic Acid in an Engineered Escherichia coli Strain

LI Xiao-lin1, 2, ZHOU Wei2, ZHUANG Yi-bin2, LU Fu-ping1, YIN Hua2   

  1. 1. School of Biological Engineering,Tianjin University of Science & Technology,Tianjin 300457;
    2. Tianjin Institute of Industrial Biotechnology,Chinese Academy of Sciences,Tianjin 300308
  • Received:2016-03-23 Online:2017-01-25 Published:2017-01-19

Abstract: 3,4-dihydroxymandelic acid,an important pharmaceutical and spices intermediate,possesses strong antioxidative and radical scavenging activities. To achieve the de novo biosynthesis of 3,4-dihydroxymandelic acid in Escherichia coli,the genes of hydroxymandelate synthase(HmaS)from Streptomyces coelicolor and 4-hydroxyphenylacetate 3-hydroxylase(HpaBC)from E. coli were cloned into pTrcHisB and overexpressed in an engineered E. coli strain MG1655/ΔA. After induction of IPTG and optimization of the inducing temperature,the yield of 3,4-dihydroxymandelic acid reached 240 mg/L in shake flask after 36 hours fermentation,laying a foundation for the large-scale fermentation production of 3,4-dihydroxymandelic acid .

Key words: Escherichia coli, 3,4-dihydroxymandelic acid, biosynthesis, HmaS, HpaBC